|
|
Blood, 1 July 2004, Vol. 104, No. 1, pp. 123-127.
Prepublished online as a Blood First Edition Paper on March 11, 2004; DOI 10.1182/blood-2003-12-4352.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa
James J. Hathcock, and
Yale Nemerson
From the Division of Thrombosis Research, Mt Sinai School of Medicine, New York, NY.
Upon plaque rupture or vascular injury, tissue factor (TF) protein in the vessel wall becomes exposed to flowing blood, initiating a cascade of reactions resulting in the deposition of fibrin and platelets on the injured site. Paradoxically, the growing thrombus may act as a barrier, restricting the convective and diffusive exchange of substrates and coagulation products between the blood and reactive vessel wall, thus limiting the role TF plays in thrombus growth. In this study, various in vitro, platelet-fibrin clots were prepared on TF:VIIa-coated surfaces and the rate at which factor (F) X in the well-mixed clot supernatant permeates the clot and is converted to Xa was monitored over several hours. The apparent diffusion coefficients of FX(a) in fibrin and platelet-fibrin clots at 37°C was 2.3 x 10–7 and 5.3 x 10–10 cm2/second, respectively, indicating that the mean time required for FX(a), and likely FIX(a), to diffuse 1 mm in a fibrin clot is 4 hours, and in the presence of platelets, 3.6 months. As complete human thrombotic occlusion has been observed within 10 minutes, an alternative source of procoagulant activity that can localize to the outer surface of growing thrombi, such as platelet factor XI or blood-borne TF, appears essential for rapid thrombus growth.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. A. Tanaka, N. S. Key, and J. H. Levy
Blood Coagulation: Hemostasis and Thrombin Regulation
Anesth. Analg.,
May 1, 2009;
108(5):
1433 - 1446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Orfeo, K. E. Brummel-Ziedins, M. Gissel, S. Butenas, and K. G. Mann
The Nature of the Stable Blood Clot Procoagulant Activities
J. Biol. Chem.,
April 11, 2008;
283(15):
9776 - 9786.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. M. Okorie, W. S. Denney, M. S. Chatterjee, K. B. Neeves, and S. L. Diamond
Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow
Blood,
April 1, 2008;
111(7):
3507 - 3513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Panes, V. Matus, C. G. Saez, T. Quiroga, J. Pereira, and D. Mezzano
Human platelets synthesize and express functional tissue factor
Blood,
June 15, 2007;
109(12):
5242 - 5250.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hoffman, A. Harger, A. Lenkowski, U. Hedner, H. R. Roberts, and D. M. Monroe
Cutaneous wound healing is impaired in hemophilia B
Blood,
November 1, 2006;
108(9):
3053 - 3060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Hathcock
Flow Effects on Coagulation and Thrombosis
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2006;
26(8):
1729 - 1737.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Monroe and M. Hoffman
What Does It Take to Make the Perfect Clot?
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2006;
26(1):
41 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
